Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Surgeon General Carmona Will Lead Import Task Force

This article was originally published in The Pink Sheet Daily

Executive Summary

Incoming CMS Administrator McClellan, FDA's Crawford and Sachdev also named to 13-member group.

You may also be interested in...



PhRMA Braces For Reimportation Fight; Job "Outsourcing" Is New Argument

Rep. Christensen warns PhRMA that the issue is becoming more difficult for Congress to fight. PhRMA's Holmer vows to press forward in case against importation.

PhRMA Braces For Reimportation Fight; Job "Outsourcing" Is New Argument

Rep. Christensen warns PhRMA that the issue is becoming more difficult for Congress to fight. PhRMA's Holmer vows to press forward in case against importation.

FDA Rx Import Task Force Will Hold Inaugural Stakeholder Meeting March 19

The group's first meeting will be with consumer organizations. FDA Commissioner McClellan is no longer chairing the task force, HHS Secretary Thompson announces.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS058862

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel